HDAC9 and cancer: It is also noteworthy that HDAC inhibitors are known to limit the growth of cancer cells and trigger their apoptosis by virtue of inducing autophagy [45, 46], while there is further evidence to suggest that IRF1 can inhibit the growth of hepatocellular carcinoma cells by inducing autophagy [35].